Molecular Testing Labs Increases Access to Diagnostic Care for CareSource Members

Share:

Collaboration enhances member experience, care journeys, and access to essential screenings at scale.

VANCOUVER, Wash. — Molecular Testing Labs (MTL), a CAP-accredited and CLIA-certified laboratory, announces a strategic collaboration with CareSource, a national nonprofit managed care organization serving more than 2 million members.Through this collaboration, CareSource members gain access to at-home, self-collected diagnostic testing, enabling them to complete essential screenings without visiting a lab. The program is designed to improve access to care, particularly for populations that face barriers such as transportation and scheduling.MTL supports the program with a multi-channel engagement strategy, including mail, text, and phone outreach to guide members through the testing process using their preferred communication channels. The program also supports care teams by increasing member participation and integrating streamlined notification and distribution features into existing clinical workflows, helping maximize efficiency and value.James York, MTL’s Chief Commercial Officer and Head of Government Affairs, highlights the partnership’s transformative potential:

“Our goal is simple: make high-quality testing easier to access and complete. We study the return and rejection data and have learned what improves returns, what reduces rejections, and what gives members confidence to complete essential screenings at home, enabling better-informed healthcare decisions.”

James York
Chief Commercial Officer & Head of Government Affairs, Molecular Testing Labs
110,000+
test kits distributed across all CareSource markets since 2025
Driving measurable improvements in test completion and reducing sample rejection rates.
Since launching in 2025, the program has already distributed more than 110,000 test kits across all CareSource markets, driving measurable improvements in test completion and reducing sample rejection rates. By making screenings easier to complete, care teams can identify potential issues and connect members to follow-up care before health concerns become more serious.

“At CareSource, we are committed to improving access to care for our members. This collaboration with MTL helps make important screenings available to members in a convenient, at-home setting. By reducing barriers to testing, we are supporting members’ ability to complete recommended screenings and access follow-up care when needed.”

Anya Alcazar
Associate Vice President, Enterprise Quality Assurance & Accreditation, CareSource
Media contact
For further information or interview requests, please contact:

Media@MolecularTestingLabs.com

Molecular Testing Labs

About Molecular Testing Labs

CareNexa, LLC dba Molecular Testing Labs is a CAP-accredited and CLIA-certified laboratory on a mission to democratize access to healthcare. By pioneering high-complexity and high-throughput diagnostic testing and decentralized lab solutions, MTL reduces barriers to care, whether it be geography, cost, stigma, and/or inconvenience. With a commitment to health equity, MTL empowers patients and providers through innovative research and development, advanced logistics, cutting-edge technology, and compassionate billing. MTL’s differentiated model combines scientific rigor, operational excellence, and inclusive access to help drive better health outcomes. For more information, visit MolecularTestingLabs.com or follow on LinkedIn.

CareSource

About CareSource

CareSource is a nonprofit, nationally recognized managed care organization with over 2 million members. CareSource administers one of the largest Medicaid managed care plans in the U.S. The organization offers health insurance, including Medicaid, Health Insurance Marketplace and Medicare products. For more information, visit www.caresource.com, or follow on X, formerly known as Twitter, LinkedIn or Facebook.

About the Author: Molecular Testing Labs